Prot # RFHE4044: A Multicenter, Randomized, Open-Label, Active-Controlled, Trial to Evaluate the Safety and Efficacy of Rifaximin 550 mg with and Without Lactulose in Subjects with a History of Recurrent Overt Hepatic Encephalopathy

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/1312/31/15

Funding

  • Salix Pharmaceuticals, Inc. (RFHE4044)